AAAAAA
Results: 1-25/58
Authors:
ORTIZ JA
BERGER RA
Citation: Ja. Ortiz et Ra. Berger, COMPARTMENT SYNDROME OF THE HAND AND WRIST, Hand clinics, 14(3), 1998, pp. 405
Authors:
PALACIN C
TARRAGO C
ORTIZ JA
Citation: C. Palacin et al., IN-VITRO ACTIVITY OF SERTACONAZOLE AGAINST MALASSEZIA-FURFUR AND PACHYDERMATIS IN DIFFERENT CULTURE MEDIA, Methods and findings in experimental and clinical pharmacology, 20(6), 1998, pp. 451-455
Authors:
ALBET C
PEREZ JAA
ROZMAN E
SACRISTAN A
ORTIZ JA
Citation: C. Albet et al., PHARMACOKINETICS OF CAMONAGREL IN EXPERIMENTAL ANIMAL - RAT, RABBIT AND DOG, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 251-254
Authors:
BRASO A
CARTHEUSER CF
PALOP D
CARCASONA C
SACRISTAN A
ORTIZ JA
Citation: A. Braso et al., HEMODYNAMIC-EFFECTS OF EBROTIDINE VERSUS RANITIDME, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 373-373
Authors:
MASCARO C
ACOSTA E
ORTIZ JA
MARRERO PF
HEGARDT FG
HARO D
Citation: C. Mascaro et al., CONTROL OF HUMAN MUSCLE-TYPE CARNITINE PALMITOYLTRANSFERASE-I GENE-TRANSCRIPTION BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR, The Journal of biological chemistry, 273(15), 1998, pp. 8560-8563
Authors:
RODRIGUEZ JC
ORTIZ JA
HEGARDT FG
HARO D
Citation: Jc. Rodriguez et al., THE HEPATOCYTE NUCLEAR FACTOR-4 (HNF-4) REPRESSES THE MITOCHONDRIAL HMG-COA SYNTHASE GENE, Biochemical and biophysical research communications, 242(3), 1998, pp. 692-696
Authors:
ARREDONDO Y
MORENOMANAS M
PLEIXATS R
PALACIN C
RAGA MM
CASTELLO JM
ORTIZ JA
Citation: Y. Arredondo et al., PREPARATION, ANTIMICROBIAL EVALUATION, AND MUTAGENICITY OF ARYL]-[1-METHYL-5-NITRO-1H-2-IMIDAZOLYL]METHANOLS, HENYL]-[1-METHYL-5-NITRO-1H-2-IMIDAZOLYL]METHANOL, AND [2-HYDROXYARYL]-[1-METHYL-5-NITRO-1H-2-IMIDAZOLYL] KETONES, Bioorganic & medicinal chemistry, 5(10), 1997, pp. 1959-1968
Authors:
FARRE M
ROSET PN
LLORENTE M
MARQUEZ M
ALBET C
PEREZ JA
HERRERO E
ORTIZ JA
Citation: M. Farre et al., CLINICAL PHARMACOKINETICS AND TOLERABILITY OF DOTARIZINE IN HEALTHY-SUBJECTS AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION, Methods and findings in experimental and clinical pharmacology, 19(5), 1997, pp. 343-350
Authors:
RODRIGUEZ JC
ORTIZ JA
HEGARDT FG
HARO D
Citation: Jc. Rodriguez et al., CHICKEN OVALBUMIN UPSTREAM-PROMOTER TRANSCRIPTION FACTOR (COUP-TF) COULD ACT AS A TRANSCRIPTIONAL ACTIVATOR OR REPRESSOR OF THE MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE GENE, Biochemical journal, 326, 1997, pp. 587-592
Authors:
ALVAREZ A
ORTIZ JA
SACRISTAN F
Citation: A. Alvarez et al., LARGE B-CELL LYMPHOMA OF THE UTERINE CORPUS - CASE-REPORT WITH IMMUNOHISTOCHEMICAL AND MOLECULAR STUDY, Gynecologic oncology, 65(3), 1997, pp. 534-538
Authors:
BOLOS J
GUBERT S
ANGLADA L
SACRISTAN A
ORTIZ JA
Citation: J. Bolos et al., SYNTHESIS OF BENZOTHIOPHENE ANALOGS OF KETOCONAZOLE AND ITRACONAZOLE, Journal of heterocyclic chemistry, 34(6), 1997, pp. 1709-1713
Authors:
ORTIZ JA
Citation: Ja. Ortiz, EBROTIDINE - A NEW GENERATION H-2-RECEPTOR ANTAGONIST AND GASTROPROTECTIVE AGENT - INTRODUCTORY OVERVIEW, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 427
Authors:
ANGLADA L
RAGA M
MARQUEZ M
SACRISTAN A
CASTELLO JM
ORTIZ JA
Citation: L. Anglada et al., SYNTHESIS AND ASSESSMENT OF FORMAMIDINES AS NEW HISTAMINE H-2-RECEPTOR ANTAGONISTS, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 431-434
Authors:
ALBET C
FERNANDEZ JM
CASTELLO JM
SACRISTAN A
ORTIZ JA
Citation: C. Albet et al., PHYSICOCHEMICAL PROPERTIES, ANALYTICAL DETERMINATIONS AND STABILITY OF EBROTIDINE, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 435-438
Authors:
PALOP D
AGUT J
MARQUEZ M
CONEJO L
SACRISTAN A
ORTIZ JA
Citation: D. Palop et al., HISTAMINE H-2-RECEPTOR ANTAGONIST ACTION OF EBROTIDINE - EFFECTS ON GASTRIC-ACID SECRETION, GASTRIN-LEVELS AND NSAID-INDUCED GASTROTOXICITYIN THE RAT, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 439-446
Authors:
AGUT J
SANCHEZ JC
SACRISTAN A
ORTIZ JA
Citation: J. Agut et al., ACTION OF EBROTIDINE, RANITIDINE AND CIMETIDINE ON THE SPECIFIC BINDING TO HISTAMINE H-1-RECEPTOR AND H-2-RECEPTOR, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 447-449
Authors:
PALOP D
ROMERO A
VILLAMAYOR F
CONEJO L
SACRISTAN A
ORTIZ JA
Citation: D. Palop et al., EFFECT OF EBROTIDINE ON ETHANOL-INDUCED GASTRIC-MUCOSAL DAMAGE IN THERAT - COMPARATIVE-STUDY WITH OTHER H-2-RECEPTOR ANTAGONISTS, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 450-454
Authors:
ROMERO A
VILLAMAYOR F
PALOP D
FALCO J
SACRISTAN A
ORTIZ JA
Citation: A. Romero et al., STUDY ON THE INCREMENT OF THE AMOUNT OF GASTRIC MUCUS IN RATS AFTER REPEATED-DOSE ADMINISTRATION OF EBROTIDINE, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 455-458
Authors:
PALOP D
CONEJO L
SACRISTAN A
ORTIZ JA
Citation: D. Palop et al., INVOLVEMENT OF ENDOGENOUS NITRIC-OXIDE AND SULFHYDRYL COMPOUNDS IN EBROTIDINE-INDUCED GASTROPROTECTION, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 468-471
Authors:
PALACIN C
TARRAGO C
SACRISTAN A
ORTIZ JA
Citation: C. Palacin et al., IN-VITRO ANTI-HELICOBACTER PYLORI ACTIVITY OF EBROTIDINE, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 471-474
Authors:
ALBET C
PEREZ JA
SACRISTAN A
ORTIZ JA
Citation: C. Albet et al., PHARMACOKINETICS OF EBROTIDINE IN RATS AND DOGS, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 483-485
Authors:
ROZMAN E
ALBET C
SACRISTAN A
ORTIZ JA
Citation: E. Rozman et al., METABOLISM OF EBROTIDINE - A REVIEW, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 486-489
Authors:
GRAU MT
ROMERO A
VILLAMAYOR F
SACRISTAN A
ORTIZ JA
Citation: Mt. Grau et al., ACUTE TOXICITY STUDIES OF EBROTIDINE, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 490-491
Authors:
ROMERO A
GRAU MT
VILLAMAYOR F
SACRISTAN A
ORTIZ JA
Citation: A. Romero et al., SUBACUTE TOXICITY OF EBROTIDINE IN RATS AND DOGS, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 492-497
Authors:
ROMERO A
GRAU MT
VILLAMAYOR F
SACRISTAN A
ORTIZ JA
Citation: A. Romero et al., CHRONIC TOXICITY OF EBROTIDINE IN RATS AND DOGS, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 498-504